These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26646310)

  • 21. Receptor-based predictors of response in breast cancer.
    McGovern UB; Stebbing J
    Future Oncol; 2009 Apr; 5(3):283-6. PubMed ID: 19374534
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative investigations of the determination of the HER-2 status in breast cancer by fluorescence and chromogenic in situ hybridization].
    Zavalishina LE; riazantseva AA; Bataeva MV; Andreeva IuIu; Frank GA
    Arkh Patol; 2008; 70(3):9-11. PubMed ID: 18727424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients.
    Naoi Y; Kishi K; Tsunashima R; Shimazu K; Shimomura A; Maruyama N; Shimoda M; Kagara N; Baba Y; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2013 Jul; 140(2):299-306. PubMed ID: 23884597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Herceptin monotherapy in HER2(+) recurrent breast carcinoma].
    Eidtmann H
    Onkologie; 2002 Dec; 25 Suppl 5():14-5. PubMed ID: 23573613
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical outcome of primary non-metastatic breast cancer: A single institution experience.
    Jamshed A; Shah MA; Syed AA; Murtaza G; Mehmood T; Chaudry SJ; Loya A; Hameed S
    Indian J Cancer; 2015; 52(1):119-25. PubMed ID: 26837998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer.
    Jensen JD; Knoop A; Ewertz M; Laenkholm AV
    Breast Cancer Res Treat; 2012 Apr; 132(2):511-21. PubMed ID: 21667123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes.
    Lo WC; Li W; Jones EF; Newitt DC; Kornak J; Wilmes LJ; Esserman LJ; Hylton NM
    PLoS One; 2016; 11(2):e0142047. PubMed ID: 26886725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocrine therapy in 2009: consideration of the tumor and the host.
    Goetz MP; Ames MM; Weinshilboum M; Ingle JN
    Oncology (Williston Park); 2009 Feb; 23(2):150-1, 154. PubMed ID: 19323295
    [No Abstract]   [Full Text] [Related]  

  • 30. Characteristics and prognosis of breast cancer after liver or kidney transplantation.
    Jeong IJ; Lee SG; Kim YH; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2018 Jan; 167(1):101-106. PubMed ID: 28914398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Impact of the 21-gene recurrence score assay in clinical treatment and prognosis analysis for patients with hormone receptor positive early-stage breast cancer].
    Zhang YN; Zhou YD; Mao F; Guan JH; Lin Y; Wang XJ; Shen SJ; Wang CJ; Yao R; Sun Q
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):110-114. PubMed ID: 29502370
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.
    Witzel ID; Milde-Langosch K; Wirtz RM; Roth C; Ihnen M; Mahner S; Zu Eulenburg C; Jänicke F; Müller V
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1709-18. PubMed ID: 20204407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ki-67 expression in operable breast cancer: a comparative study of immunostaining and a real-time RT-PCR assay.
    Potemski P; Pluciennik E; Bednarek AK; Kusinska R; Kubiak R; Jesionek-Kupnicka D; Watala C; Kordek R
    Pathol Res Pract; 2006; 202(7):491-5. PubMed ID: 16678980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting OncoDx recurrence scores with immunohistochemical markers.
    Bradshaw SH; Pidutti D; Gravel DH; Song X; Marginean EC; Robertson SJ
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):490-6. PubMed ID: 23455176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-Dimensional microarray analysis of estrogen signal-related genes in breast cancer tissues.
    Matsumoto M; Sakamoto H; Yamaguchi Y; Seino Y; Takei H; Kurosumi M; Sasano H; Yaegashi N; Hayashi S
    Anticancer Res; 2009 Oct; 29(10):3971-5. PubMed ID: 19846938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What's new in breast oncology: RT-PCR assay is effective predictor of risk and response.
    Connery KL
    JAAPA; 2010 Apr; 23(4):53-4. PubMed ID: 20411640
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas.
    Emmadi R; Canestrari E; Arbieva ZH; Mu W; Dai Y; Frasor J; Wiley E
    PLoS One; 2015; 10(12):e0145346. PubMed ID: 26717565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer.
    Callari M; Cappelletti V; D'Aiuto F; Musella V; Lembo A; Petel F; Karn T; Iwamoto T; Provero P; Daidone MG; Gianni L; Bianchini G
    Clin Cancer Res; 2016 Jan; 22(2):337-45. PubMed ID: 26423797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applying new Magee equations for predicting the Oncotype Dx recurrence score.
    Sughayer M; Alaaraj R; Alsughayer A
    Breast Cancer; 2018 Sep; 25(5):597-604. PubMed ID: 29691722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.